Inflectra
Inflectra
Inflectra (Infliximab-dyyb) is a biosimilar of Remicade. It is indicated for the treatment of Crohn’s Disease, pediatric Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Plaque Psoriasis. Inflectra is administered as an intravenous infusion.
Administration Information
Inflectra infusions are generally administered every six to eight weeks, and infusions are given over a period of about 2 hours. Infusions may be given more frequently at the start of therapy, known as the induction period. Sometimes pre-medications are administered prior to infusions, such as steroids, benadryl, or tylenol. An observation time may be required after your infusion.
Potential Side Effects
The most common side effects of Inflectra include respiratory infections, cough, stomach pain and headache.
Inflectra can lower the ability of your immune system to fight infections.
Your doctor should test you for tuberculosis and hepatitis B before starting Inflectra.
Patient Forms
Before you attend your first appointment at Omega Health, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices and Patient Rights and Responsibilities are for reference only. Please contact us if you have any questions!
Patient Consent Form
Print & Sign
HIPAA Privacy Authorization Form
Print & Sign
Notice of Privacy Practice
Read
Patient Rights and Responsibilities
Read
Appointment Lateness and Cancelation
Read
